City of Carrollton Defective Breast Mesh & Implant Attorneys: Attorney911 (The Manginello Law Firm, PLLC) Features Ralph Manginello’s 27+ Years of Federal Trial Experience and Lupe Peña’s Fluent-Spanish Consultations as a Former Insurance Defense Attorney, $50M+ Recovered & Prosecuting the $10M Bermudez Institutional-Liability Lawsuit, We Litigate Allergan BIOCELL (Recalled July 2019, MDL 2921 Before Judge Martinotti, Oct 19, 2026 Bellwether), Mentor MemoryGel, Sientra OPUS, AlloDerm, Strattice & GalaFLEX P4HB Scaffolds, BIA-ALCL CD30+/ALK- Pathology, BIA-SCC and Capsular Contracture via 21 CFR Parts 803, 807 & 814, Riegel Parallel-Claim Survivability and Lohr 510(k) Non-Preemption, Texas Civil Practice & Remedies Code § 16.003 2-Year Statute Plus Discovery Rule for 7-10 Year Latency — No Fee Unless We Recover Compensation for You, Free 24/7 Consultation, Hablamos Español, 1-888-ATTY-911
Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in City of Carrollton: The Complete Guide for Women, Families, and Survivors For women in City of Carrollton, the decision to undergo breast surgery—whether for reconstruction after a mastectomy, a prophylactic procedure due to a BRCA1 or BRCA2 mutation, or an aesthetic augmentation—is deeply personal and often involves a significant emotional journey. When you trust the medical devices used in your body, you are relying on the manufacturer’s promise that those products are designed for your safety. However, for many women in City of Carrollton and the surrounding Denton County area, that trust has been broken by defective acellular dermal matrices (ADM), surgical meshes, and bioabsorbable scaffolds like GalaFLEX and Phasix. We understand that finding out your surgery failed or that you have been diagnosed with a rare cancer like BIA-ALCL is a moment of profound crisis. At The Manginello Law Firm, PLLC, operating under the brand Attorney911, we believe that survivors in City of Carrollton deserve more than just legal representation; they deserve a firm with the technical command of FDA regulations and the scientific substrate of pathology to fight back against multibillion-dollar device manufacturers. Managing Partner Ralph…